Trisura Group Ltd header image

Trisura Group Ltd

TSU

Equity

ISIN null / Valor 39541784

Toronto Stock Exchange (2026-02-23)
CAD 45.29-2.71%

Trisura Group Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Trisura Group Ltd is a specialty insurance provider that operates primarily in the property and casualty (P&C) insurance and reinsurance sectors. The company is publicly traded on the Toronto Stock Exchange under the symbol TSU. Trisura focuses on delivering tailored insurance solutions, leveraging its expertise in niche markets to offer products such as surety, risk solutions, and corporate insurance. The company is known for its strategic approach to capital allocation and investment management, which is overseen by its leadership team with significant experience in the financial and insurance industries. Trisura's business model emphasizes innovation and adaptability, allowing it to effectively manage risks and meet the evolving needs of its clients.

Summarized from source with an LLMView SourceSector: Finance

Latest Results (20.01.2026):

Trisura Group Ltd — Q3 2025: The company reported solid quarterly results with net income of $38.6 million and operating net income of $34.4 million for the third quarter of 2025. Gross premiums written (GPW) rose 11.2% year-over-year to $853.7 million, operating diluted EPS was $0.71 (EPS $0.79), book value per share was $18.90 (up 20.8% YoY), and operating ROE was 18.0%. The combined ratio for Q3 2025 was 86.0%, supported by higher net investment income and positive non-operating investment results.

Key financials (Q3 2025)

GPW $853.7M (+11.2% YoY); Net insurance revenue $197.3M (+6.4% YoY); Underwriting income $27.6M (-4.7% YoY); Operating EBT $45.5M (+4.1% YoY); Net investment income $20.1M (+23.8% YoY); Net gains (losses) on investments ~ $7.8M (pre-tax items reported in MD&A).

Underwriting performance

Combined ratio 86.0% (up 1.6 pts YoY) comprised of a loss ratio of 34.3% and expense ratio of 51.7%. Underwriting income was slightly lower quarter-over-quarter but remained profitable; consolidated underwriting trends were affected by a shift in business mix toward specialty lines and higher corporate-level expenses.

Trisura Specialty (Q3 2025)

Specialty GPW $275.6M; Underwriting income / Operating EBT $19.5M. Primary lines (Surety, Corporate Insurance, Warranty) drove net insurance revenue growth. Surety and Warranty showed notable growth and contributed materially to Specialty results, while Canadian fronting volumes softened versus prior year.

Trisura US Programs (Q3 2025)

US Programs GPW $578.2M (+18.1% YoY); Operating EBT $8.1M. Fee income was $22.3M for the quarter; retention rate ~10.0%. Results were impacted by the strategic non-renewal/run-off of certain programs (“Exited lines”), which reduced reported revenue and fee income but left ongoing programs showing underlying growth.

Investment and non-operating items

Net investment income increased to $20.1M in Q3 2025 (driven by interest and dividend income). Net gains/losses and other non-operating items produced positive non-operating results (net of tax), with Q3 non-operating results reported at $4.1M (includes realized/unrealized investment movements, FX and derivative impacts). Movement in the yield curve and some derivative-related volatility were noted.

Capital, returns and balance sheet

Book value per share $18.90 (+20.8% YoY). Operating ROE 18.0% (ROE 15.1%). Debt-to-capital ratio 13.0% (up from 11.6% YoY) after additional borrowings to further capitalize the US Surety balance sheet; still below the stated long-term target of 20%.

Other notable items

Exited lines generated a small Q3 net loss (~$0.375M) and remain presented separately as non‑operating/run‑off business. Management continues to refine segment and non‑IFRS reporting measures (effective Q1/Q3 2025) to align with how the business is managed and measured.

Summarized from source with an LLMView Source

Key figures

33.1%1Y
30.0%3Y
42.3%5Y

Performance

28.4%1Y
29.1%3Y
34.4%5Y

Volatility

Market cap

1565 M

Market cap (USD)

Daily traded volume (Shares)

109,592

Daily traded volume (Shares)

1 day high/low

39.03 / 37.61

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Just Group PLC
Just Group PLC Just Group PLC Valor: 22735961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%GBP 2.17
First Merchants Corp
First Merchants Corp First Merchants Corp Valor: 930630
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.82%USD 40.75
Bank of Cyprus Holdings Plc
Bank of Cyprus Holdings Plc Bank of Cyprus Holdings Plc Valor: 34855173
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 9.46
Land Securities Group PLC R.E.I.T
Land Securities Group PLC R.E.I.T Land Securities Group PLC R.E.I.T Valor: 38223229
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.60%GBP 6.64
Aviva PLC
Aviva PLC Aviva PLC Valor: 118133044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.22%GBP 6.47
Hancock Whitney Corporation
Hancock Whitney Corporation Hancock Whitney Corporation Valor: 937554
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.59%USD 67.91
F&G Annuities & Life Inc
F&G Annuities & Life Inc F&G Annuities & Life Inc Valor: 123151371
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-8.48%USD 23.32
Close Brothers Group PLC
Close Brothers Group PLC Close Brothers Group PLC Valor: 379148
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.43%GBP 4.84
Norion Bank AB
Norion Bank AB Norion Bank AB Valor: 120393676
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.87%SEK 57.80
Oruka Therapeutics Inc
Oruka Therapeutics Inc Oruka Therapeutics Inc Valor: 137943588
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.03%USD 33.32